- Home
- CVR vs LYRA Comparison
CVR vs LYRA Comparison
Compare CVR & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVR
- LYRA
- Stock Information
- Founded
- CVR 1920
- LYRA 2005
- Country
- CVR United States
- LYRA United States
- Employees
- CVR N/A
- LYRA N/A
- Industry
- CVR Industrial Machinery/Components
- LYRA Medical/Dental Instruments
- Sector
- CVR Industrials
- LYRA Health Care
- Exchange
- CVR Nasdaq
- LYRA Nasdaq
- Market Cap
- CVR 14.9M
- LYRA 11.8M
- IPO Year
- CVR N/A
- LYRA 2020
- Fundamental
- Price
- CVR $15.00
- LYRA $0.18
- Analyst Decision
- CVR
- LYRA Buy
- Analyst Count
- CVR 0
- LYRA 5
- Target Price
- CVR N/A
- LYRA $4.50
- AVG Volume (30 Days)
- CVR 1.8K
- LYRA 923.9K
- Earning Date
- CVR 03-27-2025
- LYRA 04-29-2025
- Dividend Yield
- CVR 0.84%
- LYRA N/A
- EPS Growth
- CVR N/A
- LYRA N/A
- EPS
- CVR N/A
- LYRA N/A
- Revenue
- CVR $29,663,473.00
- LYRA $1,471,000.00
- Revenue This Year
- CVR N/A
- LYRA N/A
- Revenue Next Year
- CVR N/A
- LYRA N/A
- P/E Ratio
- CVR N/A
- LYRA N/A
- Revenue Growth
- CVR N/A
- LYRA 3.37
- 52 Week Low
- CVR $13.40
- LYRA $0.16
- 52 Week High
- CVR $22.27
- LYRA $6.79
- Technical
- Relative Strength Index (RSI)
- CVR 55.06
- LYRA 41.06
- Support Level
- CVR $13.40
- LYRA $0.18
- Resistance Level
- CVR $14.79
- LYRA $0.20
- Average True Range (ATR)
- CVR 0.45
- LYRA 0.01
- MACD
- CVR 0.06
- LYRA -0.00
- Stochastic Oscillator
- CVR 100.00
- LYRA 9.23
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment. Geographically, the majority is from the United States.
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.